136 related articles for article (PubMed ID: 9216828)
1. (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
Gauthier S; Caron B; Cloutier J; Dory YL; Favre A; Larouche D; Mailhot J; Ouellet C; Schwerdtfeger A; Leblanc G; Martel C; Simard J; Mérand Y; Bélanger A; Labrie C; Labrie F
J Med Chem; 1997 Jul; 40(14):2117-22. PubMed ID: 9216828
[No Abstract] [Full Text] [Related]
2. Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3222-9. PubMed ID: 2258908
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
Sharma AP; Saeed A; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3216-22. PubMed ID: 2258907
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.
Saeed A; Sharma AP; Durani N; Jain R; Durani S; Kapil RS
J Med Chem; 1990 Dec; 33(12):3210-6. PubMed ID: 2258906
[TBL] [Abstract][Full Text] [Related]
5. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
[TBL] [Abstract][Full Text] [Related]
6. Resolution, molecular structure and biological activities of the D- and L-enantiomers of potent anti-implantation agent, DL-2-[4-(2-piperidinoethoxy)phenyl]-3-phenyl-2H-1-benzopyran.
Hajela K; Pandey J; Dwivedy A; Dhar JD; Sarkhel S; Maulik PR; Velumurugan D
Bioorg Med Chem; 1999 Sep; 7(9):2083-90. PubMed ID: 10530958
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Oct; 303(1):196-203. PubMed ID: 12235251
[TBL] [Abstract][Full Text] [Related]
8. Duration of antiestrogenecity of compound CDRI-85/287: a new orally active nonsteroidal antiimplantation agent.
Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Nov; 30(11):968-71. PubMed ID: 1293041
[TBL] [Abstract][Full Text] [Related]
9. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
Martel C; Labrie C; Bélanger A; Gauthier S; Mérand Y; Li X; Provencher L; Candas B; Labrie F
Endocrinology; 1998 May; 139(5):2486-92. PubMed ID: 9564862
[TBL] [Abstract][Full Text] [Related]
11. Antifertility potential of 2-[piperdinoethoxyphenyl]-3-[4- methoxyphenyl]-2H benzopyran: a potent anti-oestrogenic compound in rats.
Singh R
J Reprod Fertil; 1996 Jan; 106(1):49-53. PubMed ID: 8667345
[TBL] [Abstract][Full Text] [Related]
12. Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity.
Jones CD; Jevnikar MG; Pike AJ; Peters MK; Black LJ; Thompson AR; Falcone JF; Clemens JA
J Med Chem; 1984 Aug; 27(8):1057-66. PubMed ID: 6431104
[TBL] [Abstract][Full Text] [Related]
13. Validated high-performance liquid chromatographic methods for quantitation of a novel nonsteroidal antiestrogen.
Coquet A; Boudreau N; Merand Y; Labrie F
J Chromatogr A; 1998 Dec; 828(1-2):247-58. PubMed ID: 9916310
[TBL] [Abstract][Full Text] [Related]
14. The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor.
Schafer JI; Liu H; Tonetti DA; Jordan VC
Cancer Res; 1999 Sep; 59(17):4308-13. PubMed ID: 10485477
[TBL] [Abstract][Full Text] [Related]
15. Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulator.
Palkowitz AD; Glasebrook AL; Thrasher KJ; Hauser KL; Short LL; Phillips DL; Muehl BS; Sato M; Shetler PK; Cullinan GJ; Pell TR; Bryant HU
J Med Chem; 1997 May; 40(10):1407-16. PubMed ID: 9154963
[TBL] [Abstract][Full Text] [Related]
16. CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus.
Sreenivasulu S; Singh MM; Dwivedi A; Setty BS; Kamboj VP
Contraception; 1992 Jan; 45(1):81-92. PubMed ID: 1591925
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice.
Luo S; Martel C; Sourla A; Gauthier S; Mérand Y; Belanger A; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(3):381-91. PubMed ID: 9359486
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
Simard J; Sanchez R; Poirier D; Gauthier S; Singh SM; Merand Y; Belanger A; Labrie C; Labrie F
Cancer Res; 1997 Aug; 57(16):3494-7. PubMed ID: 9270018
[TBL] [Abstract][Full Text] [Related]
19. A selective estrogen receptor modulator for the treatment of hot flushes.
Wallace OB; Lauwers KS; Dodge JA; May SA; Calvin JR; Hinklin R; Bryant HU; Shetler PK; Adrian MD; Geiser AG; Sato M; Burris TP
J Med Chem; 2006 Feb; 49(3):843-6. PubMed ID: 16451049
[TBL] [Abstract][Full Text] [Related]
20. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
